Leptomeningeal Contrast Enhancement Is Associated with Disability Progression and Grey Matter Atrophy in Multiple Sclerosis
Leptomeningeal contrast enhancement (LMCE) on magnetic resonance imaging (MRI) is a newly recognized possible biomarker in multiple sclerosis (MS), associated with MS progression and cortical atrophy. In this study, we aimed to assess the prevalence of LMCE foci and their impact on neurodegeneration...
Saved in:
| Main Authors: | Gleb Makshakov, Evgeniy Magonov, Natalia Totolyan, Vladimir Nazarov, Sergey Lapin, Alexandra Mazing, Elena Verbitskaya, Tatiana Trofimova, Vladimir Krasnov, Maria Shumilina, Alexander Skoromets, Evgeniy Evdoshenko |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2017-01-01
|
| Series: | Neurology Research International |
| Online Access: | http://dx.doi.org/10.1155/2017/8652463 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effect of cardiovascular diseases on the course of multiple sclerosis (review of literature)
by: N. A. Neofidov, et al.
Published: (2020-02-01) -
DIAGNOSTIC AND PROGNOSTIC SIGNIFICANCE OF INTRATHECAL SYNTHESIS OF IMMUNOGLOBULIN FREE LIGHT CHAINS IN MULTIPLE SCLEROSIS
by: V. D. Nazarov, et al.
Published: (2015-06-01) -
Molecular mechanism of neurodegeneration in spinal muscular atrophy
by: A. I. Vlasenko, et al.
Published: (2024-09-01) -
Quantitative and structural features of the SMN1 and SMN2 genes in patients with spinal muscular atrophy 5q
by: A. I. Vlasenko, et al.
Published: (2024-12-01) -
OPPORTUNITIES OF ANTI B-CELL THERAPY IN MULTIPLE SCLEROSIS
by: E. P. Evdoshenko, et al.
Published: (2014-07-01)